Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma

Yann Christinat, Liza Ho, Sophie Clément, Catherine Genestie, Jalid Sehouli, Antonio Gonzalez Martin, Ursula Denison, Keiichi Fujiwara, Ignace Vergote, Germana Tognon, Sakari Hietanen, Isabelle Ray-Coquard, Eric Pujade-Lauraine, Thomas A. McKee
doi: https://doi.org/10.1101/2022.08.22.22278669

Data Availability

All data in the present study produced from the TCGA cohort are available upon reasonable request to the authors. All data in the present study produced from the PAOLA-1 trial data are unavailable.

Data Availability

All data in the present study produced from the TCGA cohort are available upon reasonable request to the authors. All data in the present study produced from the PAOLA-1 trial data are unavailable.

Back to top
Posted August 23, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma
Yann Christinat, Liza Ho, Sophie Clément, Catherine Genestie, Jalid Sehouli, Antonio Gonzalez Martin, Ursula Denison, Keiichi Fujiwara, Ignace Vergote, Germana Tognon, Sakari Hietanen, Isabelle Ray-Coquard, Eric Pujade-Lauraine, Thomas A. McKee
medRxiv 2022.08.22.22278669; doi: https://doi.org/10.1101/2022.08.22.22278669
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area